Pages that link to "Item:Q4244513"
From MaRDI portal
The following pages link to TWO-SAMPLE CONTINUAL REASSESSMENT METHOD (Q4244513):
Displaying 14 items.
- Efficiency of bridging between related dose finding studies (Q357429) (← links)
- Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control (Q454783) (← links)
- Continual reassessment and related dose-finding designs (Q903292) (← links)
- Dose finding with escalation with overdose control (EWOC) in cancer clinical trials (Q903293) (← links)
- Design efficiency in dose finding studies (Q956828) (← links)
- A Bayesian adaptive design in cancer phase I trials using dose combinations in the presence of a baseline covariate (Q1733138) (← links)
- Individualized dosing for multiple ordered groups of patients (Q2320813) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Theoretical study of the continual reassessment method (Q2492919) (← links)
- Continual Reassessment Method for Ordered Groups (Q3079132) (← links)
- Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates (Q3549405) (← links)
- Patient-specific dose finding in phase I clinical trials (Q5036370) (← links)
- The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Quasi‐Likelihood Approach (Q5427414) (← links)
- Bayesian adaptive design of early-phase clinical trials for precision medicine based on cancer biomarkers (Q6637080) (← links)